scispace - formally typeset
K

Koji Iijima

Researcher at Mayo Clinic

Publications -  79
Citations -  3979

Koji Iijima is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Immune system & Immunology. The author has an hindex of 26, co-authored 61 publications receiving 3289 citations. Previous affiliations of Koji Iijima include University of Rochester.

Papers
More filters
Journal ArticleDOI

IL-33–Responsive Lineage−CD25+CD44hi Lymphoid Cells Mediate Innate Type 2 Immunity and Allergic Inflammation in the Lungs

TL;DR: A subset of innate immune cells that responds to IL-33 and vigorously produces Th2-type cytokines is present in mouse lungs, which may provide a novel mechanism for type 2 immunity in the airways and induction of allergic airway diseases such as asthma.
Journal ArticleDOI

A novel IL-1 family cytokine, IL-33, potently activates human eosinophils.

TL;DR: IL-33 and its receptor, ST2, may play important roles in eosinophil-mediated inflammation; they may provide new therapeutic targets for controlling mucosal eOSinophilic inflammation.
Journal ArticleDOI

The Danger Signal, Extracellular ATP, Is a Sensor for an Airborne Allergen and Triggers IL-33 Release and Innate Th2-Type Responses

TL;DR: Airway exposure of naive mice to a common environmental aeroallergen, the fungus Alternaria alternata, induces rapid release of IL-33 into the airway lumen, followed by innate Th2-type responses, and ATP and purinergic signaling in the respiratory epithelium are critical sensors for airway exposure to airborne allergies.
Journal ArticleDOI

Group 2 innate lymphoid cells and CD4+ T cells cooperate to mediate type 2 immune response in mice

TL;DR: This work sought to investigate the capacity of ILC2s to regulate effector functions of T cells in innate lymphoid cells and found it to be able to mediate the immune pathology of asthma even without adaptive immunity.